San Francisco Conference personal notes

New Post Public Reply Private Reply Replies (1) Message Board
TechGuru
673
I always like to summarize for myself every interview as this represent a direct window into the company through NP eyes, so to speak, this is revealing, in large part due to Nader’s candor. The text in blue are excerpts from direct quotes from his presentation : The emphasis is mine.

His introduction: “CytoDyne doesn’t have 30 different products has one product but we believe has 30 different indications … many more that Humira”.
“We filed BTD with FDA today in base of stunning results”


NP did not refer to the stock price as he often does when is talking to us through the Christine Corado interviews (was well-advised to do so as he was talking mainly to potential investors), however he threw a couple of cute “grenades” (If this is possible) to them: “our stock has quadrupled, we think is close to $1.2 right now, just in the last 20 days because what happened in the cancer world” (nice to hear but I believe it was more due to the commercialization deal) and, in taking about monotheraphy: “As we found how to get the response at more than 95% post first 10 weeks of enrollment we realized that we had something that GILD analyst two years ago was right, he said: that is this little company, CytoDyne is successful at monotherapy and a big pharma take him there will be a huge pushback on the sales of GILD, many people laughed at that time but there are not doing it any more. We are talking to many people that are interested in this now.”
Je, je,je Well done Nader … i.e. You guys better go to the ATM and come back with some serious money before is too late !!!

Referring to what Dr. SACHA said: “You know what you have in your hands ? the future of prevention on HIV”. We are targeting once-a-month injections and good hint for investors about more money-making-indications.

Also, expecting the delivery of half a Billion worth of Leronlimab 2Q of 2020 (if I understood correctly this amounts to around 8300 doses @ $60K each one) with deferred payment.

“Now we are saying, our key opinion leaders believe that we have More than other 20 other cancer indications, and we are able to enroll emergency IND we hoping to file a basket trial very soon so everybody can get involved in a multi-patient expanded access. 10 indications of autoimmune deceases”
“Our strategy is use our patent, borrow money, money is coming in because of our warrants getting exercised”.
And later: “so our strategy: lets the warrant get exercised have enough money up-list and the future will see whether we are likely to build the next GILD or not”

So no mention of dilution by the time being, warrants are being exercises and money is getting in, nice touch. There will be need for money in the future but investors don’t want to hear about dilution in the near term.

“I think These are good times for CytoDyne and for people to pay a lot of attention because if these things are coming out the way it is and if the BTD today, everybody can read the results of what is out there, come through and we get breakthrough designation we believe we can save a lot of lives in the world from this deadly disease”. Yes Sir !!!

In summary: a solid, enthusiastic, factual and sophisticated delivery (the latest because he said a lot in-between lines and wetted the appetite of the possible investors in a subtle way). I am sure they are on their boards making calculations as we speak.

Also, left the door open (we are talking to many people that are interested in this now) for a big whale to come and taste some tuna.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

DarioHealth's New Research Tackles Healthcare Cost Estimation

Updated Category News Views 124

Unpacking Dario's Bold Surgical Strike at ISPOR Europe Alright, folks, DarioHealth is shaking up the stage with their new methodology that could very well carve a new path in how we size up digital healthcare savings. Presented at ISPOR Europe 2026, Dario's tactic bypasses the sluggish wait on medical claims data, instead offering an evidence-driven peek at potential...

Continue Reading
DoGo Power Revamps Energy for Remote Indonesian Isle

Updated Category News Views 131

Bringing Light to Pagerungan Kecil Island These days, if you wander into the fishing communities of Pagerungan Kecil Island, the buzz isn't just from the daily catch. Residents are talking about power, and not the kind you get from a generator spluttering along—I'm talking about a brand-new energy storage system that’s turning the lights on in ways these folks have...

Continue Reading
Mercari and Suruga-ya Forge U.S. Venture for Culture

Updated Category News Views 189

Japanese Pop Culture Gears Up for US Market Surge Alright, folks, what we’ve got here is another bold move in the cross-border e-commerce game. Mercari and Suruga-ya are teaming up to establish a joint venture over in the U.S. The goal? To further capitalize on the growing appetite for Japanese entertainment and hobby goods among us all stateside. Now, it’s no secret...

Continue Reading
SwitchBot's Hub 4: A Step Toward a Connected Future

Updated Category News Views 67

Turning a House Into a Smart Home Haven Out of Tokyo and onto the world stage, SwitchBot's got something new cooking that might just shake up the smart home scene. They've launched the Hub 4, a gadget that's like the Swiss Army knife of home control. For those who like things simple, this is a one-hub-to-rule-them-all kind of deal. 101,000 Reasons to Notice Now, they...

Continue Reading
Sabre Unveils AI Travel Tech: A Bold New Frontier

Updated Category News Views 19

Sabre's Game-Changing AI Travel Integration I'm no stranger to bold moves in the travel industry, but what Sabre's rolling out tomorrow might just be the biggest leap we've seen in a while. They're unleashing what's called the first global travel plug-in within Grok Bot, marking a significant shake-up in the travel tech sphere. Too many tech upgrades in this business...

Continue Reading
XKIG Bolsters Northwest with Jensen's Acquisition

Updated Category News Views 29

Stepping Up the Game in the Pacific Northwest Well, here we see another classic example of a shrewd move in the infrastructure sector. XKIG, a name known to those who keep an eye on critical infrastructure services for utilities, has decided to widen its footprint with a strategic grab of Jensen's Tree Service, Inc. They’re setting up shop even deeper in the Pacific...

Continue Reading
Sharon Stuart's Quest for Her Hidden Origins

Updated Category News Views 55

Delving Into Identity: A Personal Odyssey In a world where everyone seems to be searching for something, Sharon Stuart's quest is etched with the raw need to uncover her real origins. Abandoned as a newborn in the gritty streets of Oakland, she grew up grappling with looming questions about what made her who she is. Her journey is captured in her memoir, "Existing Without...

Continue Reading
Graphic Packaging Shakes Up Leadership and Supply Chain

Updated Category News Views 81

New Leadership Takes the Helm at Graphic Packaging What do you do when you want to streamline an operation that spans continents? Well, if you're Graphic Packaging Holding Company (NYSE: GPK), you bring in fresh leadership to serenade the chaos into a well-oiled machine. Starting December 1, 2026, D. Keith Hamilton will be sinking his teeth into North America Mills &...

Continue Reading
IQSTEL's Nine-Month Revenue Hits $313M, Growth Impresses

Updated Category News Views 107

Pushing Through With Persistence Well, well, well, here we are, talking about IQSTEL Inc. (NASDAQ: IQST) slinging some serious numbers—not the kind you can ignore at your breakfast table. The company pulled in a whopping $313 million in revenue over the first nine months of 2026. That’s a bump up by 34.5% from last year’s $232.7 million. What’s behind the magic...

Continue Reading
Tenax Class Action: Investors Alley Fight for Redress

Updated Category News Views 33

Tenax Therapeutics in Hot Water Over Drug Trial Results Amidst the ever-unpredictable tides of the pharmaceutical industry, here comes a doozy – Tenax Therapeutics, Inc. is neck-deep in a shareholder lawsuit. If you tossed some money at NASDAQ:TENX anytime between November 13, 2023, and August 7, 2026, you might be feeling the sting of regret, and rightly so. What Went...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Unique Features of Ontomir (OTM) on BitMart

Updated Category News Views 315

Ontomir (OTM) Launches on BitMart Exchange In the world of digital assets, BitMart, a leading global trading platform, has recently showcased its commitment to innovation by announcing the listing of Ontomir (OTM). This launch marks a significant milestone for Ontomir, as the OTM/USDT trading pair becomes available, creating new opportunities for investors. Understanding...

Continue Reading
Vanguard Introduces New Actively Managed Bond ETF for Investors

Updated Category News Views 199

Vanguard Unveils a New Actively Managed Bond ETF Today, Vanguard has proudly introduced the Vanguard Multi-Sector Income Bond ETF (VGMS), a new offering in the realm of actively managed fixed-income exchange-traded funds (ETFs). This innovative product is supervised by the Vanguard Fixed Income Group, known for its extensive expertise in the field. A Commitment to...

Continue Reading
U.S. Markets Experience Mixed Trading Amid Oil Inventory Declines

Updated Category News Views 95

Mixed Performance of U.S. Stocks U.S. stocks displayed a mixed performance during the mid-week trading session, with the S&P 500 edging slightly lower. The markets reacted to various financial reports and inventory levels that influenced trader sentiments. Index Updates The Dow Jones recorded a modest increase, up by 0.08% to 42,267.94. In contrast, the NASDAQ saw a...

Continue Reading
Alignment Healthcare's Strategic Presentation Insights

Updated Category News Views 162

Alignment Healthcare's Upcoming Presentation Alignment Healthcare, Inc. (NASDAQ: ALHC) is making waves in the healthcare sector as it gears up for an important presentation at a renowned healthcare conference. This significant event will take place in January, showcasing the company's commitment to transforming senior care. The Conference Details On January 15, 2025, at...

Continue Reading
Unveiling Talen Energy's Options Trading Trends and Insights

Updated Category News Views 185

Insights into Talen Energy's Recent Options Activity Whales, those significant players in the financial markets, have recently shown a strong bullish interest in Talen Energy. This interest is reflected in a notable increase in options trading activity regarding Talen Energy (NASDAQ: TLN). Understanding the Trading Trends for TLN Within the recent options trading history...

Continue Reading